From: Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up
MMC group | OLO group | P a | |
---|---|---|---|
3rd month | 14.7(3.9; 12.9-16.4) | 15.0(3.8; 13.3-16.7) | 0.806 |
44.5 % | 45.1 % | ||
6th month | 14.7(4.3; 12.7-16.6) | 14.1(3.1; 12.6-15.4) | 0.615 |
44.5 % | 48.4 % | ||
12th month | 15.0(3.0; 13.6-16.4) | 15.2(2.8; 13.8-16.4) | 0.828 |
43.4 % | 44.3 % | ||
24th month | 16.0(2.9; 14.6-17.4) | 16.5(2.1; 15.5-17.4) | 0.536 |
39.6 % | 39.5 % | ||
36th month | 15.6 (2.6; 14.3-16.9) | 15.9 (2.5; 14.6-17.2) | 0.706 |
39.8 % | 40.2 % | ||
48th month | 15.9 (2.6; 14.5-17.2) | 15.3 (3.4; 13.4-17.1) | 0.563 |
38.8 % | 42.3 % | ||
60th month | 15.2 (3.2; 13.4-16.9) | 15.8 (±2.3; 14.4-17.1) | 0.579 |
41.0 % | 42.1 % |